Bern Pollock uses close to 10 products from different manufacturers to manage his urostomy after bladder cancer. He explains why Medicare bidding concerns him.
|Articles|November 18, 2019
Stomach Cancer Awareness Month: What You Need to Know
Author(s)Jessica Skarzynski
November is Stomach Cancer Awareness Month. Here's a round up of the latest news and updates in this disease space.
Advertisement
For Stomach Cancer Awareness Month, here’s a round-up of the latest news and updates in this disease space:
- After turning to Debbie’s Dream, one woman shares how receiving support from fellow caregivers of loved ones with stomach cancer led to her to call on home health nurses throughout her husband’s journey.
- Back in June, the Food and Drug Administration approved Kanjinti, a biosimilar to the US-licensed Herceptin, which is currently used to treat HER2 overexpressing metastatic gastric or gastroesophageal junction adenocarcinoma.
- In this story from our spring issue, we look at how emerging facts about the genetics that drive gastric cancer are leading to new treatments for the disease.
- Overall survival in metastatic gas­tric or gastroesophageal junction cancer improved significantly in patients who received the oral combination chemo­therapy Lonsurf regardless of whether they’d had a gastrectomy.
- This piece looks at why there’s a greater responsibility than ever to understand gastric cancer, its causes and its treatments.
"Stomach Cancer Awareness Month" used with permission from
Advertisement
Related to this article
A metastatic breast cancer survivor shares how exercise gave her a sense of control while emphasizing why it should never be used to blame people with cancer.
A long-term metastatic ovarian cancer survivor explains how a trifecta of hope, purpose and grace has shaped her life through years of treatment.
Six-year PERSEUS results show 81% of newly diagnosed, transplant-eligible myeloma patients had no cancer progression, with many stopping Darzalex.
A phase 3 trial found that adding Imdelltra to Imfinzi maintenance improved survival in extensive-stage small cell lung cancer, while another drug's application was pulled. Here's what patients should know.
Living with metastatic breast cancer can make Pinktober feel complicated. One patient reflects on awareness, research, loss and remembering the people behind the pink.
A leukemia survivor recalls how bonding with other patients helped his hospital stays go by faster and became a key part of his emotional healing.
Learn how nipple-sparing mastectomy, including endoscopic approaches, may help preserve appearance, reduce scarring and support breast cancer recovery.
Advertisement
Advertisement
Trending on CURE
1
Phase 3 Trial Shows Adding Imdelltra to First-Line Treatment Helps Patients With SCLC Live Longer
2
Six Years Later, Most Myeloma Patients on a Darzalex Regimen Are Still Progression-Free
3
5 Years of Breast Cancer Advances: A Timeline of FDA Approvals and What They Mean for Patients
4
10 Cancer Treatment Approvals From September 2026 and What They Mean for You
5